Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

NCT02657356 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
202
Enrollment
INDUSTRY
Sponsor class

Stopped Exposure of these high-risk patients to clinic or in-person visits during the pandemic presented an unacceptable risk to their health

Conditions

Interventions

Sponsor

Biogen